Список литературы

Поставить закладку

Арутюнян ВМ, Акопян ГС. Периодическая болезнь (этиопатогенетические и клинические аспекты). Москва: : МИА 2000.
Амарян ГГ, Саркисян ТФ, Айрапетян АС. Семейная средиземноморская лихорадка у детей (периодическая болезнь): клинические и генетические аспекты. Методическое пособие. Ереван: 2012.
Fedorov ES, Salugina SO, Kuzmina NN. Familial Mediterranean fever (a periodic disease): The present-day view of the problem. Mod Rheumatol J. 15 март 2013 г.;0(1):24.
Ben-Chetrit E, Touitou I. Familial Mediterranean Fever in the World. Arthritis Rheum. 15 октябрь 2009 г.;61(10):1447–53.
Gattorno M, редактор. Familial Mediterranean Fever [Интернет]. Cham: Springer International Publishing; 2015 [цитируется по 2 октябрь 2022 г.]. (Rare Diseases of the Immune System; т. 3). Доступно на: http://link.springer.com/10.1007/978-3-319-14615-7
Ben-Zvi I, Herskovizh C, Kukuy O, Kassel Y, Grossman C, Livneh A. Familial Mediterranean fever without MEFV mutations: a case–control study. Orphanet J Rare Dis. декабрь 2015 г.;10(1):34.
Marek-Yagel D, Berkun Y, Padeh S, Abu A, Reznik-Wolf H, Livneh A, и др. Clinical disease among patients heterozygous for familial mediterranean fever. Arthritis Rheum. июнь 2009 г.;60(6):1862–6.
Hentgen V, Grateau G, Kone-Paut I, Livneh A, Padeh S, Rozenbaum M, и др. Evidence-based recommendations for the practical management of Familial Mediterranean Fever. Semin Arthritis Rheum. декабрь 2013 г.;43(3):387–91.
The International FMF Consortium. Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean Fever. Cell. август 1997 г.;90(4):797–807.
Fedorov ES, Salugina SO. Familial Mediterranean fever (periodic disease): history or a real problem. Mod Rheumatol J. 16 сентябрь 2018 г.;12(3):61–9.
Hashkes PJ, Laxer RM, Simon A, редакторы. Textbook of Autoinflammation [Интернет]. Cham: Springer International Publishing; 2019 [цитируется по 2 октябрь 2022 г.]. Доступно на: http://link.springer.com/10.1007/978-3-319-98605-0
Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, и др. Country as the primary risk factor for renal amyloidosis in familial mediterranean fever. Arthritis Rheum. май 2007 г.;56(5):1706–12.
Federici S, Vanoni F, Ben-Chetrit E, Cantarini L, Frenkel J, Goldbach-Mansky R, и др. An International Delphi Survey for the Definition of New Classification Criteria for Familial Mediterranean Fever, Mevalonate Kinase Deficiency, TNF Receptor–associated Periodic Fever Syndromes, and Cryopyrin-associated Periodic Syndrome. J Rheumatol. апрель 2019 г.;46(4):429–36.
Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. Am J Med. август 1967 г.;43(2):227–53.
Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40:1879–85. doi:10.1002/1529-0131(199710)40:10<1879::AID-ART23>3.0.CO;2-M.
Yalçınkaya F, Özen S, Özçakar ZB, Aktay N, Çakar N, Düzova A, и др. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology. апрель 2009 г.;48(4):395–8.
Gattorno M, Hofer M, Federici S, Vanoni F, Bovis F, Aksentijevich I, и др. Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis. август 2019 г.;78(8):1025–32.
18. Federici S, Sormani MP, Ozen S, Lachmann HJ, Amaryan G, Woo P, и др. Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers. Ann Rheum Dis. май 2015 г.;74(5):799–805.
Özçakar ZB, Çakar N, Uncu N, Çelikel BA, Yalçınkaya F. Familial Mediterranean fever-associated diseases in children. QJM. 30 декабрь 2016 г.;hcw230.
Demir S, Sag E, Dedeoglu F, Ozen S. Vasculitis in Systemic Autoinflammatory Diseases. Front Pediatr. 3 декабрь 2018 г.;6:377.
Yildiz M, Adrovic A, Tasdemir E, Baba-zada K, Aydin M, Koker O, и др. Evaluation of co-existing diseases in children with familial Mediterranean fever. Rheumatol Int. январь 2020 г.;40(1):57–64.
Balcı-Peynircioğlu B, Kaya-Akça Ü, Arıcı ZS, Avcı E, Akkaya-Ulum ZY, Karadağ Ö, и др. Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients. Rheumatology. 1 июнь 2020 г.;59(6):1372–80.
Sönmez HE, Batu ED, Demir S, et al. Comparison of patients with familial Mediterranean fever accompanied with sacroiliitis and patients with juvenile spondyloarthropathy. Clin Exp Rheumatol 2017;35 Suppl 108:124–7.
Ozer E, Seker D, Taner E, et al. The frequency of juvenile spondyloarthropathies in childhood familial Mediterranean fever. Clin Exp Rheumatol 2018;36:141–5.
Рамеев ВВ, Симонян АХ, Саркисова ИА, et al. Амилоидоз и наследственные периодические аутовоспалительные заболевания. Клиницист 2008;3.https://www.elibrary.ru/item.asp?id=14310188 (accessed 28 May 2021).
Vinceneux P, Pouchot J. De la maladie périodique à l’amylose. Presse Médicale. июль 2005 г.;34(13):958–66.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney inter 2013;3:1–150.
Lidar M, Yaqubov M, Zaks N, et al. The prodrome: a prominent yet overlooked pre-attack manifestation of familial Mediterranean fever. J Rheumatol 2006;33:1089–92.
Yenokyan G, Armenian HK. Triggers for Attacks in Familial Mediterranean Fever: Application of the Case-Crossover Design. Am J Epidemiol. 15 май 2012 г.;175(10):1054–61.
Petty RE, Laxer RM, Lindsley CB, et al. Textbook of pediatric rheumatology. 8th ed. Philadelphia: : Elsevier, Inc 2020.
Кузьмина НН, Салугина СО, Федоров ЕС. Аутовоспалительные заболевания и синдромы у детей. Москва: : ИМА-ПРЕСС 2012.
Sari I, Birlik M, Kasifoglu T Familial Mediterranean fever: An update review. 2014;1:21-33.
Alghamdi M. Familial Mediterranean fever, review of the literature. Clin Rheumatol. август 2017 г.;36(8):1707–13.
Ozdogan H, Ugurlu S. Familial Mediterranean Fever. Presse Médicale. февраль 2019 г.;48(1):e61–76.
Alsarah A, Alsara O, Laird-Fick HS. Cardiac manifestations of Familial Mediterranean fever. Avicenna J Med. октябрь 2017 г.;07(04):158–63.
Salah S, Hegazy R, Ammar R, Sheba H, AbdelRahman L. MEFV gene mutations and cardiac phenotype in children with familial Mediterranean fever: a cohort study. Pediatr Rheumatol. декабрь 2014 г.;12(1):5.
Gurkan OE, Dalgic B. Gastrointestinal Mucosal Involvement Without Amyloidosis in Children With Familial Mediterranean Fever. J Pediatr Gastroenterol Nutr. сентябрь 2013 г.;57(3):319–23.
Tutar E, Kutluk G, Bayrak NA, Ataizi Celikel C, Pehlivanoglu E, Ertem D. What is the diagnostic utility of endoscopic scoring systems in children? Turk J Gastroenterol. 1 февраль 2009 г.;24(1):22–9.
Beşer ÖF, Kasapçopur Ö, Çokuğraş FÇ, Kutlu T, Arsoy N, Erkan T. Association of Inflammatory Bowel Disease With Familial Mediterranean Fever in Turkish Children. J Pediatr Gastroenterol Nutr. май 2013 г.;56(5):498–502.
Sağ E, Demir F, Saygın İ, Kalyoncu M, Çakır M. Endoscopic Findings of Children with Familial Mediterranean Fever. Pediatr Gastroenterol Hepatol Nutr. 2018 г.;21(4):271.
Petrushkin H, Stanford M, Fortune F, Jawad AS. Clinical Review: Familial Mediterranean Fever—An Overview of Pathogenesis, Symptoms, Ocular Manifestations, and Treatment. Ocul Immunol Inflamm. 3 июль 2016 г.;24(4):422–30.
Баранов АА, Алексеева ЕИ, editors. Ревматические болезни у детей. Москва: : ПедиатрЪ 2016.
Adrovic A, Sahin S, Barut K, Kasapcopur O. Familial Mediterranean fever and periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: shared features and main differences. Rheumatol Int. январь 2019 г.;39(1):29–36.
Korkmaz C. Acute phase response in familial Mediterranean fever. Ann Rheum Dis. 1 январь 2002 г.;61(1):79–81.
Тепаев РФ. Синдром диссеминированного внутрисосудистого свертывания у детей. Диагностика и лечение. Педиатрическая Фармакология 2010;7:27–31.
De Vere-Tyndall A, Macauley D, Ansell BM. Disseminated intravascular coagulation complicating systemic juvenile chronic arthritis (”Still’s disease”). Clin Rheumatol. декабрь 1983 г.;2(4):415.
Ören H, Cingöz I, Duman M, Yılmaz S, Irken G. DISSEMINATED INTRAVASCULAR COAGULATION IN PEDIATRIC PATIENTS: Clinical and Laboratory Features and Prognostic Factors Influencing the Survival. Pediatr Hematol Oncol. январь 2005 г.;22(8):679–88.
Rajagopal R, Thachil J, Monagle P. Disseminated intravascular coagulation in paediatrics. Arch Dis Child. февраль 2017 г.;102(2):187–93.
Tayer-Shifman O. E., Ben-Chetrit E. Familial Mediterranean fever and hypercoagulability //Mediterranean journal of hematology and infectious diseases. – 2011. – Т. 3. – №. 1.
Salah S. et al. Comparing D-dimer status in children with familial Mediterranean fever during and in between acute attacks //The Egyptian Rheumatologist. – 2018. – Т. 40. – №. 2. – С. 107-110.
Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G, и др. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis. апрель 2016 г.;75(4):644–51.
Fraisse T. et al. Non‐amyloid liver involvement in familial Mediterranean fever: A systematic literature review //Liver International. – 2020. – Т. 40. – №. 6. – С. 1269-1277.
Celkan T. et al. The anemia of familial Mediterranean fever disease //Pediatric hematology and oncology. – 2005. – Т. 22. – №. 8. – С. 657-665.
Mohamed R. et al. Carotid intima-media thickness, lipid profile, serum amyloid A and vitamin D status in children with familial Mediterranean fever //The Egyptian Rheumatologist. – 2020. – Т. 42. – №. 3. – С. 237-240.
Unal F. et al. Liver involvement in children with Familial Mediterranean fever //Digestive and Liver Disease. – 2012. – Т. 44. – №. 8. – С. 689-693.
Topouzian N. B., Bowie L. J. Familial Mediterranean fever in a fraternal twin: a laboratory evaluation //Annals of Clinical & Laboratory Science. – 1991. – Т. 21. – №. 3. – С. 205-215.
Uyanik A, Albayrak F, Uyanik MH, Dursun H, Keles M, Cetinkaya R. Antibodies directed to cyclic citrullinated peptides in familial Mediterranean fever. Rheumatol Int. февраль 2010 г.;30(4):467–71.
Kholoussi S, Kholoussi N, Zaki ME, El-Bassyouni HT, Elnady H, Morcos B, и др. Immunological Evaluation in Patients with Familial Mediterranean fever. Open Access Maced J Med Sci. 9 февраль 2018 г.;6(2):310–3.
Karatay S, Yildirim K, Erdal A, Uzkeser H, Erdem FH, Yanmaz V. Anti-cyclic citrullinated peptide antibodies are not associated with familial Mediterranean fever. J Back Musculoskelet Rehabil. 5 март 2010 г.;23(1):21–3.
Majeed HA. Familial Mediterranean fever in children: the expanded clinical profile. QJM. 1 июнь 1999 г.;92(6):309–18.
Kaşifoğlu T, Çalışır C, Cansu DÜ, Korkmaz C. The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis. Clin Rheumatol. январь 2009 г.;28(1):41–6.
Периодические лихорадки в практике детского врача / Р. Р. Шиляев, Е. Б. Копилова, Е. В. Харитонова, И. В. Менагаришвили // Вестник Ивановской медицинской академии. – 2013. – Т. 18. – № 4. – С. 51-55.
Saatçi Ü. et al. Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis //European journal of pediatrics. – 1997. – Т. 156. – №. 8. – С. 619-623.
Said R. et al. Spectrum of renal involvement in familial Mediterranean fever //Kidney international. – 1992. – Т. 41. – №. 2. – С. 414-419.
Özer S. et al. Simple markers for subclinical inflammation in patients with Familial Mediterranean Fever //Medical Science Monitor: İnternational medical journal of experimental and clinical research. – 2015. – Т. 21. – С. 298.
Bourguiba R, Savey L, Aouba A, Deshayes S, Fain O, Martin-Silva N, и др. Le syndrome de fièvre prolongée associée aux mutations du gène du récepteur au TNF de type 1 : un diagnostic différentiel de la fièvre méditerranéenne familiale à ne pas méconnaître chez les patients d’origine méditerranéenne. Rev Médecine Interne. июль 2021 г.;42(7):459–64.
Sag E, Bilginer Y, Ozen S. Autoinflammatory Diseases with Periodic Fevers. Curr Rheumatol Rep. июль 2017 г.;19(7):41.
Soon GS, Laxer RM. Approach to recurrent fever in childhood. Can Fam Physician Med Fam Can 2017;63:756–62.
Yüksel S, Ekim M, Özçakar ZB, Yalçınkaya F, Acar B, Öztuna D, и др. The value of procalcitonin measurements in children with familial Mediterranean fever. Rheumatol Int. ноябрь 2012 г.;32(11):3443–7.
Щербина АЮ. Первичные иммунодефициты -реалии XXI века. Вопросы Гематологиионкологии И Иммунопатологии В Педиатрии. 2016;15:8-9–9. doi:10.24287/1726-1708-2016-15-1-8-9.
Selmi C, Gershwin ME. Diagnosis and classification of reactive arthritis. Autoimmun Rev. апрель 2014 г.;13(4–5):546–9.
Steffen, Hirsch. Diagnostik der Lyme-Borreliose. Ther Umsch. 1 ноябрь 2005 г.;62(11):737–44.
Sood SK. Lyme Disease in Children. Infect Dis Clin North Am. июнь 2015 г.;29(2):281–94.
for the Paediatric Rheumatology International Trials Organisation (PRINTO), Giancane G, Swart JF, Castagnola E, Groll AH, Horneff G, и др. Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee. Arthritis Res Ther. декабрь 2020 г.;22(1):71.
McAuley JB. Toxoplasmosis in Children. Pediatr Infect Dis J. февраль 2008 г.;27(2):161–2.
Cascio A., Colomba C. Childhood Mediterranean visceral leishmaniasis //Le Infezioni in Medicina. – 2003. – Т. 11. – №. 1. – С. 5-10.
Howell MD, Davis AM. Management of Sepsis and Septic Shock. 2017 г.;2.
Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP, и др. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med. февраль 2020 г.;46(S1):10–67.
Demirbaş F, Çaltepe G, Comba A, Abbasguliyev H, Uyar NY, Kalaycı AG. Fecal calprotectin in children with familial Mediterranean fever in the attack‐free period. Pediatr Int. ноябрь 2019 г.;61(11):1140–5.
Asan G, Derin ME, Doğan HO, Bayram M, Şahin M, Şahin A. Can Calprotectin Show Subclinical Inflammation in Familial Mediterranean Fever Patients? J Korean Med Sci. 2020 г.;35(10):e63.
Hudgins K. Porphyria: A Rare, Complicated, and Misdiagnosed Disease. Crit Care Nurs Q. апрель 2019 г.;42(2):192–7.
Baresic M, Karanovic B, Coen Herak D, et al. Misleading symptoms of hereditary angioedema type II mimicking familial mediterranean fever. Acta Reumatol Port 2020;45:143–6.
Kazandjieva J, Christoff G. Angioedema as a systemic disease. Clin Dermatol. ноябрь 2019 г.;37(6):636–43.
Ziegeler K, Eshed I, Diekhoff T, Hermann KG. Imaging of Joints and Bones in Autoinflammation. J Clin Med. 17 декабрь 2020 г.;9(12):4074.
Ishak GE, Khoury NJ, Birjawi GA, El-Zein YR, Naffaa LN, Haddad MC. Imaging findings of familial Mediterranean fever. Clin Imaging. май 2006 г.;30(3):153–9.
Aharoni D, Hiller N, Hadas-Halpern I. Familial Mediterranean fever: abdominal imaging findings in 139 patients and review of the literature. Abdom Imaging. март 2000 г.;25(3):297–300.
Ruemmele FM, Veres G, Kolho KL, Griffiths A, Levine A, Escher JC, и др. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn’s disease. J Crohns Colitis. 1 октябрь 2014 г.;8(10):1179–207.
Canpolat M, Gumus H, Gunduz Z, Dusunsel R, Kumandas S, Bayram A, и др. Neurological Manifestations in Familial Mediterranean Fever: Results of 22 Children from a Reference Center in Kayseri, an Urban Area in Central Anatolia, Turkey. Neuropediatrics. 22 сентябрь 2016 г.;48(02):079–85.
Zucker EJ, Lee EY, Restrepo R, Eisenberg RL. Hip Disorders in Children. Am J Roentgenol. декабрь 2013 г.;201(6):W776–96.
Olmedilla G, Undaondo C, Vasquez W, Rodriguez N. Metastatic Malignant Peritoneal Mesothelioma Mimicking an Autoinflammatory Syndrome in a 12-Year-Old Boy. Pediatr Dev Pathol. сентябрь 2021 г.;24(5):478–83.
Fonseca MB, Gomes FHR, Valera ET, Pileggi GS, Gonfiantini PB, Gonfiantini MB, и др. Signs and symptoms of rheumatic diseases as first manifestation of pediatric cancer: diagnosis and prognosis implications. Rev Bras Reumatol Engl Ed. июль 2017 г.;57(4):330–7.
Grebenyuk V. et al. Fever of unknown origin: case reports from routine clinical practice and a review //Klinicka Mikrobiologie a Infekcni Lekarstvi. – 2021. – Т. 27. – №. 4. – С. 148-157.
Li Q. et al. Quantifying the contribution of 18F-FDG PET to the diagnostic assessment of pediatric patients with fever of unknown origin: a systematic review and meta-analysis //Pediatric Radiology. – 2022. – С. 1-12.
Tantawy A. A. G., Ebeid F. S. E., k El Sherif N. H. Reversible Posterior Leukoencephalopathy Syndrome Complicating Therapy of Hodgkin Disease in A Child with Familial Mediterranean Fever: A Case Report //American Journal of Cancer Case Reports. – 2013. – Т. 1. – №. 1. – С. 8-15.
Erbis G, Schmidt K, Hansmann S, Sergiichuk T, Michler C, Kuemmerle-Deschner JB, и др. Living with autoinflammatory diseases: identifying unmet needs of children, adolescents and adults. Pediatr Rheumatol. декабрь 2018 г.;16(1):81.
Yokota S, Itoh Y, Morio T, Sumitomo N, Daimaru K, Minota S. Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab. J Rheumatol. апрель 2015 г.;42(4):712–22.
Rossi-Semerano L, Hermeziu B, Fabre M, Koné-Paut I. Macrophage activation syndrome revealing familial Mediterranean fever. Arthritis Care Res. май 2011 г.;63(5):780–3.
Ravelli A, Davì S, Minoia F, Martini A, Cron RQ. Macrophage Activation Syndrome. Hematol Oncol Clin North Am. октябрь 2015 г.;29(5):927–41.
Rigante D, Emmi G, Fastiggi M, Silvestri E, Cantarini L. Macrophage activation syndrome in the course of monogenic autoinflammatory disorders. Clin Rheumatol. август 2015 г.;34(8):1333–9.
Valade S, Mariotte E, Azoulay E. Coagulation Disorders in Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome. Crit Care Clin. апрель 2020 г.;36(2):415–26.
Yuan W-H, Liu H-C, Zeng L-K, et al. [Change of Thrombelastography in Children’s DIC and Analysis of Its Sensitivity and Specificity for Diagnosis of DIC]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2017;25:847–52. doi:10.7534/j.issn.1009-2137.2017.03.039.
Limper M, de Kruif MD, Duits AJ, Brandjes DPM, van Gorp ECM. The diagnostic role of Procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J Infect. июнь 2010 г.;60(6):409–16.
Cantini F, Nannini C, Niccoli L, Iannone F, Delogu G, Garlaschi G, и др. Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice. Autoimmun Rev. июнь 2015 г.;14(6):503–9.
Handa R, Upadhyaya S, Kapoor S, Jois R, Pandey BD, Bhatnagar AK, и др. Tuberculosis and biologics in rheumatology: A special situation. Int J Rheum Dis. октябрь 2017 г.;20(10):1313–25.
Vince A, Dusek D. Imunosupresija i virusne infekcije u reumatskim bolestima [Immunosupression and viral infections in rheumatic diseases]. Reumatizam. 2007;54(2):58-62. Croatian. PMID: 18351141.
Eroglu‐Ertugrul NG, Yalcin E, Oguz B, Ocal T, Kuskonmaz B, Emiralioglu N, и др. The value of flexible bronchoscopy in pulmonary infections of immunosuppressed children. Clin Respir J. февраль 2020 г.;14(2):78–84.
Gonski K, Cohn R, Widger J, McMullan B. Utility of bronchoscopy in immunocompromised paediatric patients: Systematic review. Paediatr Respir Rev. апрель 2020 г.;34:24–34.
Özkoç S, Bayram Deli̇Baş S. Investigation of Pneumocystis jirovecii Pneumonia and Colonization in Iatrogenically Immunosuppressed and Immunocompetent Patients. Mikrobiyol Bul. 24 апрель 2015 г.;49(2):221–30.
Lachant DJ, Croft DP, McGrane Minton H, Hardy DJ, Prasad P, Kottmann RM. The clinical impact of pneumocystis and viral PCR testing on bronchoalveolar lavage in immunosuppressed patients. Respir Med. декабрь 2018 г.;145:35–40.
Ramos JT, Romero CA, Belda S, et al. Clinical practice update of antifungal prophylaxis in immunocompromised children. Rev Espanola Quimioter Publicacion Of Soc Espanola Quimioter 2019;32:410–25.
Tragiannidis A, Kyriakidis I, Zündorf I, Groll AH. Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-α) inhibitors. Mycoses. апрель 2017 г.;60(4):222–9.
García-Basteiro AL, DiNardo A, Saavedra B, Silva DR, Palmero D, Gegia M, и др. Point of care diagnostics for tuberculosis. Pulmonology. март 2018 г.;24(2):73–85.
Kisla Ekinci RM, Balcı S, Bisgin A, Cetin F, Tumgor G. The contribution of diet preference to the disease course in children with familial Mediterranean fever: a cross-sectional study. Reumatologia/Rheumatology. 2020 г.;58(2):81–6.
Kazem Y, Zarouk WA, Hamed K, et al. The Effect of Anti-inflammatory Diet and Vitamin D Supplementation on the Amelioration of the Clinical Status and Cognitive functions of Familial Mediterranean Fever Patients. Kobe J Med Sci 2021;66:E159–65.
Stucki G, Kroeling P. Physical therapy and rehabilitation in the management of rheumatic disorders. Best Pract Res Clin Rheumatol. декабрь 2000 г.;14(4):751–71.
Luttosch F, Baerwald C. Rehabilitation in der Rheumatologie. Internist. октябрь 2010 г.;51(10):1239–45.
Sherman JM, Sood SK. Current challenges in the diagnosis and management of fever. Curr Opin Pediatr. июнь 2012 г.;24(3):400–6.
ter Haar N, Lachmann H, Özen S, Woo P, Uziel Y, Modesto C, и др. Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis. май 2013 г.;72(5):678–85.
Levy DM, Imundo LF. Nonsteroidal Anti-Inflammatory Drugs: A survey of practices and concerns of pediatric medical and surgical specialists and a summary of available safety data. Pediatr Rheumatol. декабрь 2010 г.;8(1):7.
Litalien C., Jacqz-Aigrain E. Risks and benefits of nonsteroidal anti-inflammatory drugs in children //Paediatric drugs. – 2001. – Т. 3. – №. 11. – С. 817-858.
Hollingworth P. The use of non-steroidal anti-inflammatory drugs in paediatric rheumatic diseases //Rheumatology. – 1993. – Т. 32. – №. 1. – С. 73-77.
Guillaume-Czitrom S. Les anti-inflammatoires non stéroïdiens dans les rhumatismes inflammatoires chroniques de l’enfant [Non -steroidal anti-inflammatory drugs in chronic inflammatory arthritis in children]. La Lettre du Rhumatologue №379-380 - février-mars 2012.
Gupta P, Sachdev HP. Safety of oral use of nimesulide in children: systematic review of randomized controlled trials. Indian Pediatr. 2003 Jun;40(6):518-31. PMID: 12824661.
Ozen S, Bilginer Y. A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin. Nat Rev Rheumatol. март 2014 г.;10(3):135–47.
Çakan M., Karadag S. G., Ayaz N. A. Corticosteroid-resistant anakinra-responsive protracted febrile myalgia syndrome as the first manifestation of familial Mediterranean fever //Northern Clinics of İstanbul. – 2020. – Т. 7. – №. 1. – С. 78.
Özkaya O. et al. Cerebral vasculitis in a child with Henoch–Schönlein purpura and familial Mediterranean fever //Clinical rheumatology. – 2007. – Т. 26. – №. 10. – С. 1729-1732.
Bakkaloğlu S. A. et al. Polyarteritis nodosa in a case of familial Mediterranean fever //Pediatric Nephrology. – 2004. – Т. 19. – №. 5. – С. 536-538.
Öztürk K., Çakan M. Protracted febrile myalgia syndrome as the first manifestation of familial Mediterranean fever in children: case-based review //Rheumatology International. – 2021. – Т. 41. – №. 1. – С. 213-218.
Ozturk MA, Kanbay M, Kasapoglu B, et al. Therapeutic approach to familial Mediterranean fever: a review update. Clin Exp Rheumatol 2011;29:S77-86.
Pankow A, Feist E, Baumann U, Kirschstein M, Burmester GR, Wagner AD. Was ist gesichert in der Therapie von autoinflammatorischen Fiebererkrankungen? Internist. декабрь 2021 г.;62(12):1280–9.
Sarikaya S., ÖZDOLAP Ş., MARAŞLI E. Spondylitis and arthritis in familial Mediterranean fever //Archives of Rheumatology. – 2012. – Т. 27. – №. 4. – С. 241-247.
Kallinich T, Haffner D, Niehues T, Huss K, Lainka E, Neudorf U, и др. Colchicine Use in Children and Adolescents With Familial Mediterranean Fever: Literature Review and Consensus Statement. Pediatrics. 1 февраль 2007 г.;119(2):e474–83.
Demirkaya E, Erer B, Ozen S, Ben-Chetrit E. Efficacy and safety of treatments in Familial Mediterranean fever: a systematic review. Rheumatol Int. март 2016 г.;36(3):325–31.
Padeh S, Gerstein M, Berkun Y. Colchicine is a Safe Drug in Children with Familial Mediterranean Fever. J Pediatr. декабрь 2012 г.;161(6):1142–6.
Ozen S, Kone-Paut I, Gül A. Colchicine resistance and intolerance in familial mediterranean fever: Definition, causes, and alternative treatments. Semin Arthritis Rheum. август 2017 г.;47(1):115–20.
Tufan A, Lachmann HJ. Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review. Turk J Med Sci. 3 ноябрь 2020 г.;50(7):1591–610.
Kuemmerle-Deschner JB, Gautam R, George AT, Raza S, Lomax KG, Hur P. A systematic literature review of efficacy, effectiveness and safety of biologic therapies for treatment of familial Mediterranean fever. Rheumatology. 1 октябрь 2020 г.;59(10):2711–24.
Hentgen V, Vinit C, Fayand A, Georgin-Lavialle S. The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review. Front Immunol. 28 май 2020 г.;11:971.
Mercan R, Turan A, Bitik B, Tufan A, Haznedaroglu S, Goker B. Rapid resolution of protracted febrile myalgia syndrome with anakinra: Report of two cases. Mod Rheumatol. 3 май 2016 г.;26(3):458–9.
Ruperto N, Murray KJ, Gerloni V, Wulffraat N, Feitosa De Oliveira SK, Falcini F, и др. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum. июль 2004 г.;50(7):2191–201.
Bakkaloglu SA, Aksu T, Goker B, Unlusoy A, Peru H, Fidan K, и др. Sulphasalazine treatment in protracted familial Mediterranean fever arthritis. Eur J Pediatr. август 2009 г.;168(8):1017–9.
Kaçmaz H. et al. Sacroiliitis in children and adolescents with familial Mediterranean fever //Advances in Rheumatology. – 2021. – Т. 61.
Langevitz P. et al. Seronegative spondyloarthropathy in familial Mediterranean fever //Seminars in arthritis and rheumatism. – WB Saunders, 1997. – Т. 27. – №. 2. – С. 67-72.
В Aydin F. et al. Sacroiliitis in children with familial Mediterranean fever //JCR: Journal of Clinical Rheumatology. – 2019. – Т. 25. – №. 2. – С. 69-73.
Yucel I. K. et al. Economic impact of juvenile idiopathic arthritis and familial Mediterranean fever //Rheumatology international. – 2012. – Т. 32. – №. 7. – С. 1955-1962.
Alexeeva E., Kozlova A., Valiyeva S., Bzarova T., Chomakhidze A., Isaeva K. NEW OPPORTUNITIES IN TREATMENT OF JUVENILE ANKYLOSING SPONDYLOARTHRITIS. Current Pediatrics. 2010;9(2):23-31.
On behalf of the Rheumatology Italian Study Group, Ferrara G, Mastrangelo G, Barone P, La Torre F, Martino S, и др. Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting. Pediatr Rheumatol. декабрь 2018 г.;16(1):46.
Woo P, Southwood TR, Prieur AM, Doré CJ, Grainger J, David J, и др. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum. август 2000 г.;43(8):1849–57.
Ozgocmen S, Akgul O. Anti-TNF agents in familial Mediterranean fever: report of three cases and review of the literature. Mod Rheumatol. декабрь 2011 г.;21(6):684–90.
Guti rrez-Su rez R., Burgos-Vargas R. The use of methotrexate in children with rheumatic diseases //Clinical and Experimental Rheumatology-Incl Supplements. – 2010. – Т. 28. – №. 5. – С. S122.
Hunt PG, Rose CD, McIlvain-Simpson G, et al. The effects of daily intake of folic acid on the efficacy of methotrexate therapy in children with juvenile rheumatoid arthritis. A controlled study. J Rheumatol 1997;24:2230–2.
Colak S, Tekgoz E, Cinar M, Yilmaz S. The assessment of tocilizumab therapy on recurrent attacks of patients with familial Mediterranean fever: A retrospective study of 15 patients. Mod Rheumatol. 2 январь 2021 г.;31(1):223–5.
Inui K, Sawa N, Suwabe T, Mizuno H, Yamanouchi M, Hiramatsu R, и др. Long term administration of tocilizumab improves renal amyloid A (AA) amyloidosis deposition in Familial Mediterranean fever. Mod Rheumatol Case Rep. 2 июль 2020 г.;4(2):310–1.
Grevich S, Shenoi S. Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition. Adolesc Health Med Ther. ноябрь 2017 г.;Volume 8:125–35.
Mitchell E, Jones G. Subcutaneous tocilizumab for the treatment of rheumatoid arthritis. Expert Rev Clin Immunol. февраль 2016 г.;12(2):103–14.
Koga T. et al. A Randomized, Double-Blind, Placebo-Controlled Phase III Trial On The Efficacy and Safety of Tocilizumab in Patients With Colchicine-Resistant or-Intolerant Familial Mediterranean Fever. – 2021.
Mulders-Manders C. M. et al. Systemic autoinflammatory diseases and Fever Syndromes. – 2020. – С. 135.
Brunner HI, Ruperto N, Tzaribachev N, Horneff G, Chasnyk VG, Panaviene V, и др. Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial. Ann Rheum Dis. январь 2018 г.;77(1):21–9.
Cherqaoui B. et al. Boundaries between familial Mediterranean fever and juvenile spondyloarthritis: Analysis of three French retrospective cohorts //Joint Bone Spine. – 2018. – Т. 85. – №. 6. – С. 733-739.
Akgul O. et al. Efficacy and safety of biologic treatments in Familial Mediterranean Fever //The American Journal of the Medical Sciences. – 2013. – Т. 346. – №. 2. – С. 137-141.
Avar-Aydin P. O. et al. Ocular inflammatory diseases in children with familial Mediterranean fever: a true association or a coincidence? //International Ophthalmology. – 2022. – Т. 42. – №. 4. – С. 1249-1257.
Scott C., Slamang W. Biologics in childhood rheumatic disorders //Current Allergy & Clinical Immunology. – 2018. – Т. 31. – №. 4. – С. 206-211.
Cabrera N. et al. Safety of biological agents in paediatric rheumatic diseases: a real-life multicenter retrospective study using the JIRcohorte database //Joint Bone Spine. – 2019. – Т. 86. – №. 3. – С. 343-350.
Paç Kısaarslan A. et al. Evaluation of familial Mediterranean fever patients concomitant with juvenile spondyloarthropathy //Modern rheumatology. – 2021. – Т. 31. – №. 3. – С. 718-724.
ter Haar NM, van Delft ALJ, Annink KV, van Stel H, Al-Mayouf SM, Amaryan G, и др. In silico validation of the Autoinflammatory Disease Damage Index. Ann Rheum Dis. ноябрь 2018 г.;77(11):1599–605.
Pras E, Livneh A, Balow JE, Pras E, Kastner DL, Pras M, и др. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet. 13 январь 1998 г.;75(2):216–9.
Babaoglu H, Armagan B, Bodakci E, et al. Factors associated with damage in patients with familial Mediterranean fever. Clin Exp Rheumatol 2020;38 Suppl 127:42–8.
Henter JI. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 18 сентябрь 2002 г.;100(7):2367–73.
La Rosée P, Horne A, Hines M, von Bahr Greenwood T, Machowicz R, Berliner N, и др. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 6 июнь 2019 г.;133(23):2465–77.
Bagri NK, Gupta L, Sen ES, Ramanan AV. Macrophage Activation Syndrome in Children: Diagnosis and Management. Indian Pediatr. декабрь 2021 г.;58(12):1155–61.
Stephan J. L. et al. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients //Rheumatology. – 2001. – Т. 40. – №. 11. – С. 1285-1292.
I.A.Kriulin IAK, Kriulin IA, National Medical Research Center for Children’s Health, Moscow, Russian Federation, I.M.Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation, Alexeeva EI, National Medical Research Center for Children’s Health, Moscow, Russian Federation, и др. Hemophagocytic lymphohistiocytosis: mechanisms of development, clinical manifestations, and treatments. Vopr Prakt Pediatr. 2021 г.;16(6):94–102.
Grom AA, Horne A, De Benedetti F. Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol. май 2016 г.;12(5):259–68.
Aizawa-Yashiro T, Oki E, Tsuruga K, Nakahata T, Ito E, Tanaka H. Intravenous immunoglobulin therapy leading to dramatic improvement in a patient with systemic juvenile idiopathic arthritis and severe pericarditis resistant to steroid pulse therapy. Rheumatol Int. май 2012 г.;32(5):1359–61.
Georgiadou S, Gatselis NK, Stefos A, Zachou K, Makaritsis K, Rigopoulou EI, и др. Efficient management of secondary haemophagocytic lymphohistiocytosis with intravenous steroids and γ-immunoglobulin infusions. World J Clin Cases. 6 ноябрь 2019 г.;7(21):3394–406.
Roifman CM. Use of intravenous immune globulin in the therapy of children with rheumatological diseases. J Clin Immunol. ноябрь 1995 г.;15(S6):S42–51.
Sen E. S., Clarke S. L. N., Ramanan A. V. Macrophage activation syndrome //The Indian Journal of Pediatrics. – 2016. – Т. 83. – №. 3. – С. 248-253.
Chellapandian D, Das R, Zelley K, Wiener SJ, Zhao H, Teachey DT, и др. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. Br J Haematol. август 2013 г.;162(3):376–82.
Siberry GK, Abzug MJ, Nachman S, Brady MT, Dominguez KL, Handelsman E, и др. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children: Recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. Pediatr Infect Dis J. ноябрь 2013 г.;32(Supplement 2):i.
Green H, Paul M, Vidal L, Leibovici L. Prophylaxis of Pneumocystis Pneumonia in Immunocompromised Non-HIV-Infected Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials. Mayo Clin Proc. сентябрь 2007 г.;82(9):1052–9.
Sulieman SE, Metjian TA, Zaoutis TE, Fisher BT. Pneumocystis Pneumonia: Epidemiology and Options for Prophylaxis in Non-HIV Immunocompromised Pediatric Patients. Curr Fungal Infect Rep. март 2014 г.;8(1):45–55.
Abe Y, Fujibayashi K, Nishizaki Y, Yanagisawa N, Nojiri S, Nakano S, и др. Conventional-dose Versus Half-dose Sulfamethoxazole-trimethoprim for the Prophylaxis of Pneumocystis Pneumonia in Patients with Systemic Rheumatic Disease: A Non-blind, Randomized Controlled Trial [Интернет]. Okayama University Medical School; 2019 [цитируется по 2 октябрь 2022 г.]. Доступно на: https://doi.org/10.18926/AMO/56464
Ghembaza A, Vautier M, Cacoub P, Pourcher V, Saadoun D. Risk Factors and Prevention of Pneumocystis jirovecii Pneumonia in Patients With Autoimmune and Inflammatory Diseases. Chest. декабрь 2020 г.;158(6):2323–32.
Jiang X, Mei X, Feng D, Wang X. Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis. Tanowitz HB, редактор. PLOS ONE. 24 апрель 2015 г.;10(4):e0122171.
Kitazawa T, Seo K, Yoshino Y, Asako K, Kikuchi H, Kono H, и др. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases. J Infect Chemother. май 2019 г.;25(5):351–4.
Park JW, Curtis JR, Kim MJ, Lee H, Song YW, Lee EB. Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids—clinical implication of primary prophylaxis using trimethoprim–sulfamethoxazole. Arthritis Res Ther. декабрь 2019 г.;21(1):207.
What’s New Adult and Adolescent Opportunistic Infection. AIDSinfo. https://aidsinfo.nih.gov/guidelines/html/4/adult-and-adolescent-opportunistic-infection/392/whats-new (accessed 14 Apr 2020).
Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, и др. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. февраль 2007 г.;48(2):124–31.
Heijstek MW, Ott de Bruin LM, Bijl M, Borrow R, van der Klis F, Koné-Paut I, и др. EULAR recommendations for vaccination in paediatric patients with rheumatic diseases. Ann Rheum Dis. октябрь 2011 г.;70(10):1704–12.
Алексеева Е., Валиева С., Бзарова Т., Семикина Е., Исаева К., Лисицин А., Денисова Р., Чистякова Е., Слепцова Т., Митенко Е. Эффективность и безопасность отечественного рекомбинантного человеческого гранулоцитарного колониестимулирующего фактора при нейтропениях, развивающихся на фоне анти-в клеточной и иммуносупрессивной терапии у больных ювенильным ревматоидным артритом. Вопросы современной педиатрии. 2010;9(4):94-100.
Yilmaz D., Ritchey A. K. Severe neutropenia in children: a single institutional experience //Journal of Pediatric Hematology/Oncology. – 2007. – Т. 29. – №. 8. – С. 513-518.
Aghdashi MA, Khadir M, Dinparasti-Saleh R. Antinuclear Antibodies and Lupus-like Manifestations in Rheumatoid Arthritis and Ankylosing Spondylitis Patients at 4 Months’ Follow-up After Treatment with Infliximab and Etanercept. Curr Rheumatol Rev. 5 март 2020 г.;16(1):61–6.
Garcia-Lloret M, McGhee S, Chatila TA. Immunoglobulin Replacement Therapy in Children. Immunol Allergy Clin North Am. ноябрь 2008 г.;28(4):833–49.
Ahmadinejad Z, Mansori S, Ziaee V, et al. Periodic Fever: a review on clinical, management and guideline for Iranian patients - part I. Iran J Pediatr 2014;24:1–13.
Chien YL, Huang FL, Huang CM, Chen PY. Clinical approach to fever of unknown origin in children. J Microbiol Immunol Infect. декабрь 2017 г.;50(6):893–8.
El-Nawawy A, El-Kinany H, Hamdy El-Sayed M, Boshra N. Intravenous Polyclonal Immunoglobulin Administration to Sepsis Syndrome Patients: A Prospective Study in a Pediatric Intensive Care Unit. J Trop Pediatr. 1 октябрь 2005 г.;51(5):271–8.
Gülez N, Makay B, Sözeri B. Long-term effectiveness and safety of canakinumab in pediatric familial Mediterranean fever patients. Mod Rheumatol. 2 январь 2020 г.;30(1):166–71.
Rao S, Abzug MJ, Carosone-Link P, Peterson T, Child J, Siparksy G, и др. Intravenous Acyclovir and Renal Dysfunction in Children: A Matched Case Control Study. J Pediatr. июнь 2015 г.;166(6):1462-1468.e4.
Whitley RJ. Herpes simplex virus in children. Curr Treat Options Neurol. май 2002 г.;4(3):231–7.
Antiviral Drugs in Children and Adolescents. Pediatr Infect Dis. 16 июль 2020 г.;1(3):123–8.
Zhang S, Zhu Y, Jin Y, Sun H, Wang W, Zhan L. Difference between Acyclovir and Ganciclovir in the Treatment of Children with Epstein–Barr Virus-Associated Infectious Mononucleosis. Tan S, редактор. Evid Based Complement Alternat Med. 20 октябрь 2021 г.;2021:1–6.
Adler SP, Marshall B. Cytomegalovirus Infections. :11.
Аксенова ВА, Барышников ЛА, Клевно НИ, et al. Новые возможности скрининга и диагностики различных проявлений туберкулезной инфекции у детей и подростков в России. Вопросы Современной Педиатрии 2011;10:16–22.
Koç R, Sönmez HE, Çakan M, Karadağ ŞG, Tanatar A, Çakmak F, и др. Drug reactions in children with rheumatic diseases receiving parenteral therapies: 9 years’ experience of a tertiary pediatric rheumatology center. Rheumatol Int. май 2020 г.;40(5):771–6.
Bockem�hl J, Roggentin P. Enterale Yersiniosen: Klinische Bedeutung, Epidemiologie, Diagnostik und Pr�vention. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz [Интернет]. июль 2004 г. [цитируется по 2 октябрь 2022 г.];47(7). Доступно на: http://link.springer.com/10.1007/s00103-004-0865-9
Sandau KE, Funk M, Auerbach A, Barsness GW, Blum K, Cvach M, и др. Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association. Circulation [Интернет]. 7 ноябрь 2017 г. [цитируется по 2 октябрь 2022 г.];136(19). Доступно на: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000527
Sharma AP, Norozi K, Filler G, Altamirano-Diaz L. Diagnosis of Pediatric Hypertension: European Society of Hypertension-recommended 24-hr vs. 24-hr-day-night Ambulatory Blood Pressure thresholds. :23.
Turner D, Levine A, Escher JC, Griffiths AM, Russell RK, Dignass A, и др. Management of Pediatric Ulcerative Colitis: Joint ECCO and ESPGHAN Evidence-based Consensus Guidelines. J Pediatr Gastroenterol Nutr. сентябрь 2012 г.;55(3):340–61.
Sierra D, Wood M, Kolli S, Felipez LM. Pediatric Gastritis, Gastropathy, and Peptic Ulcer Disease. Pediatr Rev. 1 ноябрь 2018 г.;39(11):542–9.
Jones NL, Koletzko S, Goodman K, Bontems P, Cadranel S, Casswall T, и др. Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016). J Pediatr Gastroenterol Nutr. июнь 2017 г.;64(6):991–1003.
Pneumonia in Immunocompromised Patients: Overview, Causes of Pneumonia, HIV/AIDS. Published Online First: 23 March 2020.https://emedicine.medscape.com/article/807846-overview#a11.. (accessed 14 Apr 2020).
Weyant RB, Kabbani D, Doucette K, Lau C, Cervera C. Pneumocystis jirovecii: a review with a focus on prevention and treatment. Expert Opin Pharmacother. 13 август 2021 г.;22(12):1579–92.
Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE, и др. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis: ACR GUIDELINE FOR GLUCOCORTICOID-INDUCED OSTEOPOROSIS PREVENTION AND TREATMENT. Arthritis Rheumatol. август 2017 г.;69(8):1521–37.
Galindo-Zavala R, Bou-Torrent R, Magallares-López B, Mir-Perelló C, Palmou-Fontana N, Sevilla-Pérez B, и др. Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children. Pediatr Rheumatol. декабрь 2020 г.;18(1):20.
Денисова Р. В., Алексеева Екатерина Иосифовна, Пинелис В. Г., Баканов М. И., Валиева С. И., Бзарова Т. М., Исаева К. Б., Морев С. Ю., Кузнецова Г. В., Арсеньева Е. Н., Малахов О. А. Эффективность и безопасность ибандроновой кислоты для внутривенного введения при тяжелом системном остеопорозе у больных ювенильным артритом // ВСП. 2011. №6.
Kutilek S, Plasilova I, Langer J. Ibandronate in the treatment of pediatric osteoporosis. Bone Abstr [Интернет]. 9 июнь 2015 г. [цитируется по 3 октябрь 2022 г.]; Доступно на: http://www.iccbh.org/2015/programme.aspx/ba/0004ba0004P80.htm
de Camargo MC, Barros BCA, Fulone I, Silva MT, Silveira MS do N, Camargo IA de, и др. Adverse Events in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Receiving Long-Term Biological Agents in a Real-Life Setting. Front Pharmacol. 11 сентябрь 2019 г.;10:965.
Puxeddu I, Giori L, Rocchi V, Bazzichi L, Bombardieri S, Tavoni A, и др. Hypersensitivity reactions during treatment with infliximab, etanercept, and adalimumab. Ann Allergy Asthma Immunol. февраль 2012 г.;108(2):123–4.
Demirkaya E, Ozen S, Türker T, Kuis W, Saurenmann RK. Current educational status of paediatric rheumatology in Europe: the results of PReS survey. Clin Exp Rheumatol. август 2009 г.;27(4):685–90.
Allen-Rhoades W, Whittle SB, Rainusso N. Pediatric Solid Tumors in Children and Adolescents: An Overview. Pediatr Rev. 1 сентябрь 2018 г.;39(9):444–53.